Contraceptive Implants: Access and Coverage in the U.S.
The contraceptive implant is the most effective method of birth control available, and while it’s use is still low compared to other methods, its provision and use are increasing.
Search
-
-
Recent State Actions Related to Immigrants’ Access to Services and Immigration Enforcement
Issue BriefThis brief summarizes recent and proposed actions by states related to access to state-funded health coverage and other services for immigrants and immigration enforcement activity during the 2025 and 2026 state legislative sessions.
-
How Employers Support Lower-Waged Workers’ Access to Health Insurance Options
Issue BriefThis analysis examines the costs, availability, and take-up of health benefits for workers with lower wages, using survey data and focus groups with more than 100 U.S. employers with over a quarter of a million employees.
-
The Latest on Medication Abortion Access: The Court Awaits the FDA Review
Quick InsightsDespite for calls from Republican leaders and anti-abortion organizations for the FDA to act quickly, the Louisiana district court has given the FDA until October 7, 2026, one month before the midterms, to file a report with the status of its review and any updated timeframe for completion. In the meantime, clinicians may continue to mail mifepristone to pregnant patients seeking abortions regardless of where they live.
-
Intrauterine Devices (IUDs): Access and Coverage in the U.S.
Fact SheetIntrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews FDA-approved IUDs, as well as use, availability, and key issues in insurance coverage and financing of IUDs in the U.S.
-
Policy Tracker: Youth Access to Gender Affirming Care and State Policy Restrictions
TrackerThis tracker provides an overview of state laws/policies restricting minor access to gender affirming care and any associated litigation by state, identifying which groups of people are impacted in addition to minors, the types of penalties providers face, the status of legal challenges, and other key information.
-
Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court
Issue BriefThis brief reviews the case now before the Supreme Court, Louisiana v. FDA, and provides an overview of the other pending litigation involving mifepristone, and the mounting tension between states seeking to protect abortion and the states banning the provision of abortion.
-
Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White
Policy WatchStates are facing constrained budgets, putting pressure on HIV programs, including the Ryan White HIV/AIDS Program. This Policy Watch explores how state Ryan White AIDS Drug Assistance Programs (ADAPs) are responding to these budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could led to negative health outcomes for people with HIV and lead to new HIV infections.
-
Health Care Access and Affordability for Adults with Multiple or Complex Health Conditions: A Snapshot of Patient Experiences
Poll FindingSignificant shares of adults with multiple or complex health conditions, including cancer, lung disease, diabetes, cardiovascular disease, and mental health conditions say they struggle to pay their medical bills and access needed care and medication. These challenges fall hardest on uninsured adults who face greater costs and access challenges.
-
A View of Medicaid Today and a Look Ahead: Balancing Access, Budgets and Upcoming Changes
ReportThis report highlights key policy priorities and issues state Medicaid programs focused on in FY 2025 and are prioritizing in FY 2026.